A system for quickly identifying infectious diseases at the point of care.
A modular platform for infectious disease surveillance at point-of-need.
This study is working on a quick and easy test that can check for several infectious diseases, like Ebola and Dengue, using just a small blood sample, so that patients can get results in under 30 minutes, helping doctors make faster decisions during outbreaks and keep track of diseases even when there aren’t any outbreaks happening.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Redbud Labs, INC. NIH-funded |
| Lab location | 1 site (Durham, UNITED STATES) |
| Project ID | NIH-10697143 on NIH RePORTER |
What this research studies
This research aims to create a rapid testing platform that can identify various infectious diseases, particularly filoviruses like Ebola and Dengue, directly at the point of need. By using a small blood sample, the system will test for multiple viral strains simultaneously, providing results in under 30 minutes. This technology is designed to improve patient triage and treatment during outbreaks and enhance disease surveillance even when outbreaks are not occurring. The approach combines advanced microfluidic technology with expertise in diagnostics to ensure accurate and timely identification of infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals presenting symptoms of infectious diseases that may require rapid diagnosis, especially during outbreaks.
Not a fit: Patients with non-infectious diseases or those not exhibiting symptoms of the targeted infectious diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose serious infectious diseases, leading to faster treatment and better outbreak management.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for infectious diseases, indicating that this approach has potential for success.
Where this research is happening
Durham, UNITED STATES
- Redbud Labs, INC. — Durham, United States (Active)
Researchers
- Principal investigator: Fisher, Jay Kenneth — Redbud Labs, INC.
- Study coordinator: Fisher, Jay Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.